SAN || Clinical News

VIDEO: A practical protocol for monitoring discoid lupus

Posted on: 23/10/2014 - 22:06

NEWPORT BEACH, CALIF.– Patients with discoid lupus should be checked routinely for systemic disease, but complete autoantibody studies aren’t necessary for those patients with a prior work-up and a...

Field of Interest: Dermatology

Type: News Item

FDA panel unanimously supports secukinumab approval for psoriasis

Posted on: 20/10/2014 - 23:15

SILVER SPRING, MD. – The human monoclonal antibody secukinumab is expected to be the first biologic that targets interleukin-17A to be approved by the agency for treating psoriasis, with a Food and...

Field of Interest: Dermatology

Type: News Item

Secukinumab showed sustained efficacy in psoriasis

Posted on: 19/10/2014 - 17:57

AMSTERDAM – The investigational biologic agent secukinumab continued to show strong efficacy through 52 weeks of treatment in a new secondary analysis of the pivotal phase III ERASURE trial. For...

Field of Interest: Dermatology

Type: News Item

Rosacea’s comorbidities are more than skin deep

Posted on: 16/10/2014 - 17:32

AMSTERDAM – Rosacea is associated with increased risk of a range of chronic systemic diseases, including allergies and urogential disorders, a case-control study showed. The common denominator...

Field of Interest: Dermatology

Type: News Item

VIDEO: MEK/BRAF combo puts brakes on BRAF-mutated advanced melanoma progression

Posted on: 03/10/2014 - 14:10

MADRID – Combining the investigational MEK inhibitor cobimetinib with the BRAF inhibitor vemurafenib nearly halved the risk of progression in previously untreated patients with BRAF-mutated advanced...

Field of Interest: Oncology

Type: News Item

More people die from thin melanomas than thick melanomas

Posted on: 02/10/2014 - 13:45

EDINBURGH – Contrary to the perception that most melanoma deaths result from thick melanomas, long-term data from Australia show that more people die who initially present with thin melanomas. Among...

Field of Interest: Dermatology

Type: News Item

Apremilast approval expanded to include plaque psoriasis

Posted on: 24/09/2014 - 20:48

The oral phosphodiesterase-4 inhibitor apremilast is now indicated for the treatment of moderate to severe plaque psoriasis. On Sept. 23, the manufacturer, Celgene, announced that the Food and Drug...

Field of Interest: Dermatology

Type: News Item

Anal high-grade squamous intraepithelial lesions cleared in 42% of gay men

Posted on: 11/09/2014 - 19:25

MELBOURNE – High-grade squamous intraepithelial lesions are prevalent among HIV-positive gay men and a significant number of these anal lesions resolve spontaneously, according to data from a...

Field of Interest: Dermatology

Type: News Item

Mobile apps get skin in the sun protection game

Posted on: 10/09/2014 - 20:05

EDINBURGH – Mobile phone apps that provide real-time, personalized sun risk and protection information are gaining ground in the fight against skin cancer. The <link...

Field of Interest: Dermatology

Type: News Item

Psoriatic arthritis patients often changed or stopped treatment

Posted on: 09/09/2014 - 22:55

Patients with psoriatic arthritis who began taking disease-modifying antirheumatic drugs often changed regimens soon afterward, especially if they had started with nonbiologic treatments, researchers...

Field of Interest: Rheumatology

Type: News Item

« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters